top of page


GrayMatters Health Header image

April 22, 2024

PR Newswire: Edison Gold Award for Prism for PTSD

March 19, 2024

APA 2024: Meet us at Booth #1628, Javits Convention Center, NYC

March 19, 2024

How this company is putting a lid on PTSD​

March 19, 2024

PR Newswire: GrayMatters Health Named to Fast Company's list of World's Most Innovative Companies (MIC) of 2024

March 6, 2024

Psychiatric Times: Study Highlights Efficacy of Prism for PTSD in Alleviating Chronic PTSD Symptoms

February 7, 2024

nocamels: Brain Activity Monitor Proves Efficacy in PTSD Therapy, Study Finds

February 6, 2024

PR Newswire: GrayMatters Health Announces Pioneering Study Highlighting Safety and Efficacy of Self-Neuromodulation for PTSD

January 4, 2024

PR Newswire: GrayMatters Launches New FDA-Cleared Self-Neuromodulation PTSD Therapy in the United States

November 30, 2023

Globes: Israeli startup GrayMatters treats PTSD with avatars

November 3, 2023

MM+M: ‘What we do matters’: Israeli mental health startup finds mission especially vital

October 26, 2023

HIT Consultant: The Future of Biomarker-Based Therapy for Mental Disorder Care by Oded Kraft, Co-Founder & CEO of GrayMatters Health

September 26, 2023

Medical Device News Magazine: GrayMatters Health Expands US Executive Team, Including Appointment of Dr Aron Tendler as Chief Medical Office

September 26, 2023

PR Newswire: GrayMatters Health Expands US Executive Team

June 21, 2023

PR Newswire: GrayMatters Health Wins 2023 Prix Galien USA Best Startup Award

June 21, 2023

PR Newswire: GrayMatters Health Appoints Kirk Thelander as Chief Commercial Officer

June 21, 2023

ISRAEL21c: Neurofeedback device helps PTSD sufferers regain control over emotions

May 02, 2023

Medgadget: Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

April 13, 2023

The Healthcare Technology Report: Retrain The Brain: GrayMatters Health Carves Out New PTSD Treatment Option

March 24, 2023

FIERCE Biotech: Neuromodulation device for PTSD treatment from GrayMatters snags FDA nod

March 20, 2023

PR Newswire: U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD

March 20, 2023

PR Newswire: GrayMatters Health Receives Investment from European Innovation Council (EIC) Fund

September 13, 2022

GrayMatters Health Chosen as a Falling Walls Venture 2022 Winner

September 7, 2022

GrayMatters Health Awarded €2.5M in Funding from European Innovation Council

January 11, 2022

PR Newswire: GrayMatters Health Closes $10M Round A Funding and Partnership in Japan

July 29, 2021

PR Newswire: McLean Hospital and GrayMatters Health Awarded BIRD Foundation Grant to Develop Digital Therapy for Major Depression Disorder with Anhedonia Symptoms

July 13, 2021

PR Newswire: GrayMatters Health Wins Awards for its Innovative Technology for the Treatment of Mental Disorders

April 9, 2021

Beyond the Pill: a startup reimagines mental health

bottom of page